Zobrazeno 1 - 10
of 94
pro vyhledávání: '"V.K.K. Chatterjee"'
Autor:
V.K.K. Chatterjee
Publikováno v:
Annales d'Endocrinologie. 69:103-106
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52487f9cc2f16c3311d39ed7ee690e8a
https://doi.org/10.1016/j.ando.2008.02.005
https://doi.org/10.1016/j.ando.2008.02.005
Autor:
V.K.K Chatterjee
Publikováno v:
International Congress Series. 1262:51-54
Peroxisome proliferator-activated receptor γ (PPARγ), mediates adipocyte differentiation and is the target for the thiazolidinedione (TZD) group of insulin-sensitising antidiabetic agents. We screened the PPARγ gene in 85 subjects with severe insu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b9fbcd5edc3b0a6a891aca01c225bc0
https://doi.org/10.1016/j.ics.2003.11.025
https://doi.org/10.1016/j.ics.2003.11.025
Publikováno v:
Gene. 236:315-323
Nuclear hormone receptors (NRs) are ligand-inducible transcription factors that mediate critical functions in many species. The majority of novel NRs have hitherto been cloned from cDNA libraries by virtue of their homology to previously identified r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6ed8ef5c34196207ad63b38e4e0f9a5
https://doi.org/10.1016/s0378-1119(99)00265-6
https://doi.org/10.1016/s0378-1119(99)00265-6
Publikováno v:
Bone. 21:137-142
The mechanism of action of thyroid hormones on bone is poorly understood. Thyroid hormones may act on bone cells either indirectly by increasing secretion of growth hormone (GH) and insulin-like growth factor-1 (IGF-1), or directly by influencing tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a91779973ac1e1ffc051646a7ff304f4
https://doi.org/10.1016/s8756-3282(97)00097-5
https://doi.org/10.1016/s8756-3282(97)00097-5
Autor:
V.K.K. Chatterjee
Publikováno v:
Hormone Research. 48:43-46
Resistance to thyroid hormone (RTH) is usually dominantly inherited and is characterized by elevated free thyroid hormones in the serum and failure to suppress pituitary thyroid stimulating hormone (TSH) secretion with variable refractoriness to horm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e3586442d2d4d5f5f821afb65879c2a
https://doi.org/10.1159/000191312
https://doi.org/10.1159/000191312
Publikováno v:
Scopus-Elsevier
Thyroid hormones have well-documented effects on the skeleton although the mechanism of their action on bone is poorly understood. We have recently reported the presence of different thyroid hormone receptor isoforms in human bone. However, there is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9592d8087d321151339bab6d3046d272
http://hdl.handle.net/11697/6099
http://hdl.handle.net/11697/6099
Publikováno v:
FEBS letters, 450(1-2), 35-38. Wiley-Blackwell
Desethylamiodarone (DEA) acts as a competitive inhibitor of triiodothyronine (T3) binding to the alpha1-thyroid hormone receptor (TR alpha1) but as a non-competitive inhibitor with respect to TR beta1. To gain insight into the position of the binding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0db4e74111794ba95513a2e054d92e26
https://pure.amc.nl/en/publications/effect-of-mutations-in-the-beta1thyroid-hormone-receptor-on-the-inhibition-of-t3-binding-by-desethylamiodarone(cae0b635-7f9c-4b75-b3ed-bc70b2e892cf).html
https://pure.amc.nl/en/publications/effect-of-mutations-in-the-beta1thyroid-hormone-receptor-on-the-inhibition-of-t3-binding-by-desethylamiodarone(cae0b635-7f9c-4b75-b3ed-bc70b2e892cf).html
Autor:
B. Adinolfi, E. Milgrom, I. Beau, R.E. Reddingius, B. Vannier, C. Capuano, G. Vassart, J. Timsit, A. Colao, A. Balestrieri, B.M. Brennan, S. Longobardi, G. Lombardi, N. Caballo, C. Terzi, D. Ferone, V. Barriosa, M. Rosilio, S. Mariotti, W.F. Blum, H. Loosfelt, M. Hernández, M. Songint, J.F. Savouret, A. Loviselli, F. Orio, M. Vanelli, Bo Carlsson, A. Attanasio, N. Ghinea, S.M. Shalet, J. Argente, B. Merola, C.L. Boguszewski, R. Cirillo, V.K. Ramiya, G. Chiari, D. Blazy, E. Larger, J. Pozo, J.-C. Carel, M.B. Ranke, M.E. Street, L.M.S. Carlsson, N.K. Maclaren, M. Misrahi, V.K.K. Chatterjee, C. Boitard, P. Froguel, J.A. Chowen, M.T. Muñoz, F. Velluzzi, G.F. Bottazzo, V. Sepe, A.P. Weetman, G. Delitala, D. Dubois, P. Nizzia, M. Elmlinger, N. de Roux, J.L. Chaussain, P. Marzullo, E. Cossu
Publikováno v:
Hormone Research in Paediatrics. 54:75-75
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be50cd89abc117a3460077d3ab92a2f1
https://doi.org/10.1159/000063452
https://doi.org/10.1159/000063452
Publikováno v:
Bone. 19:688
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c608e2669d3b046f3bb73b2e3f5c764
https://doi.org/10.1016/s8756-3282(97)84313-x
https://doi.org/10.1016/s8756-3282(97)84313-x
Publikováno v:
British Journal of Diseases of the Chest. 80:288-291
We describe a patient who developed rapid irreversible blindness following treatment with ethambutol in the recommended dose of 15 mg/kg body weight which in clinical practice is widely considered to be safe. This case exemplifies the potential risks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6b2767ad8123c85a7f1943f54cb9cde
https://doi.org/10.1016/0007-0971(86)90066-5
https://doi.org/10.1016/0007-0971(86)90066-5